The neurobiology of Alcohol Use Disorder

Andrea de Bejczy, M.D, Ph.D, is a senior researcher and head of the Clinical Trial Section of the Addiction Biology Unit at Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry at the Sahlgrenska Academy, University of Gothenburg and has a leading role in alcohol studies as at the Department of Addiction and Dependency, Sahlgrenska University Hospital. Andrea de Bejczy’s main research area is randomized controlled trials on new pharmacotherapies for alcohol dependence, with focus on drugs targeting the dopamine system. A parallel focus for de Bejczy’s research is bio-markers in alcohol dependence.

1. Substitution therapy in alcohol treatment, with a focus on mechanisms and possibilitiesJulien Guiraud2. Designing and analyzing studies on treatments for alcohol dependenceKatie Witkiewitz3. The harm reduction approach for treatment of alcohol dependenceDavid Nutt4. Current treatments for alcohol dependence, with a suggested focus on mechanisms and possibilitiesGiovanni Addolorato5. Metabolomics in relation to alcohol dependence with focus on possibilities for precision medicineOlli Kärkkäinen6. Repurposing drugs for treatment of alcohol dependenceHenri-Jean Aubin